Aliases & Classifications for Papilloma

MalaCards integrated aliases for Papilloma:

Name: Papilloma 12 51 14 69
Papillomatosis 12 51 69
Papillomatosis, Nos 12
Papillomatosis Nos 12

Classifications:



External Ids:

Disease Ontology 12 DOID:2615
MeSH 41 D010212
NCIt 46 C3713 C7440

Summaries for Papilloma

Disease Ontology : 12 A cell type benign neoplam that is composed_of epithelial tissue on papillae of vascularized connective tissue.

MalaCards based summary : Papilloma, also known as papillomatosis, is related to inverted papilloma and frontal sinus inverted papilloma. An important gene associated with Papilloma is UBE3A (Ubiquitin Protein Ligase E3A), and among its related pathways/superpathways are Developmental Biology and Endometrial cancer. The drugs Cervarix and Cidofovir have been mentioned in the context of this disorder. Affiliated tissues include breast, testes and skin, and related phenotypes are cellular and growth/size/body region

Related Diseases for Papilloma

Diseases related to Papilloma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 417)
# Related Disease Score Top Affiliating Genes
1 inverted papilloma 34.1 CDKN2A KRT13 KRT20 TP53
2 frontal sinus inverted papilloma 33.8 KRT13 KRT5
3 bladder transitional cell papilloma 33.7 CDKN1A TP53
4 inverted transitional papilloma 33.6 CDKN2A KRT5
5 anogenital venereal wart 32.7 CDKN2A TP53 UBE3A
6 urinary tract papillary transitional cell benign neoplasm 32.4 KRT20 TP53
7 li-fraumeni syndrome 32.0 CDKN1A CDKN2A PTEN TP53
8 cervical cancer 31.1 CDKN1A CDKN2A RB1 TP53 UBE3A
9 oral squamous cell carcinoma 30.8 CDKN1A CDKN2A KRT13 TP53
10 adenocarcinoma 30.7 CDKN1A CDKN2A RB1 TP53
11 suppressor of tumorigenicity 3 30.7 CDKN1A CDKN2A RB1 TP53 UBE3A
12 oral cancer 30.6 CDKN2A KRT13 TP53
13 squamous cell carcinoma 30.6 CDKN1A CDKN2A IVL PTEN RB1 TP53
14 transitional cell carcinoma 30.5 KRT20 KRT8 TP53
15 retinoblastoma 30.4 CDKN1A CDKN2A RB1 TP53
16 squamous cell carcinoma, head and neck 30.4 CDKN1A CDKN2A PTEN RB1 TP53
17 lymphoepithelioma-like carcinoma 30.3 KRT20 KRT5 KRT8
18 squamous cell carcinoma of the oropharynx 30.2 CDKN2A TP53
19 meningioma, familial 30.2 CDKN2B IGF2 PTEN TP53
20 cervical squamous cell carcinoma 30.2 CDKN2A KRT8 TP53
21 ductal carcinoma in situ 30.1 KRT14 KRT5 KRT8 TP53
22 tongue cancer 30.1 CDKN1A CDKN2A KRT13 TP53
23 keratoacanthoma 30.1 CDKN1A FLG KRT10 TP53
24 bladder squamous cell carcinoma 30.1 CDKN2A PTEN TP53
25 epidermodysplasia verruciformis 30.0 FLG KRT10 KRT14
26 endometrial adenocarcinoma 30.0 CDKN2A PTEN TP53
27 adenosquamous carcinoma 30.0 KRT5 KRT8 TP53
28 actinic keratosis 30.0 CDKN2A KRT20 TP53
29 vulvar intraepithelial neoplasia 29.9 KRT10 TP53
30 cervical adenocarcinoma 29.9 CDKN1A CDKN2A KRT20 TP53
31 bowenoid papulosis 29.9 CDKN2A FLG
32 basaloid squamous cell carcinoma 29.8 CDKN2A KRT13 KRT14 KRT8 TP53
33 bladder cancer 29.8 CDKN1A CDKN2A CDKN2B KRT20 KRT8 RB1
34 astrocytoma 29.8 CDKN2A CDKN2B PTEN TP53
35 small cell cancer of the lung 29.8 CDKN2A KRT20 RB1 TP53
36 glioblastoma 29.7 CDKN1A CDKN2A PTEN RB1 TP53
37 in situ carcinoma 29.6 CDKN2A KRT14 KRT5 TP53
38 squamous cell carcinoma of the larynx 29.5 CDKN2A TP53
39 lichen planus 29.4 FLG IVL KRT10 KRT13 TP53
40 esophageal cancer 29.3 CDKN1A CDKN2A CDKN2B FSCN1 PTEN RB1
41 keratosis 29.3 CDKN2A FLG IVL KRT10 TP53
42 large cell acanthoma 29.2 KRT10 KRT14 KRT5
43 basal cell carcinoma 27.3 CDKN1A CDKN2A IVL KRT10 KRT14 KRT20
44 papilloma of choroid plexus 12.5
45 squamous cell papilloma 12.3
46 intraductal papilloma 12.2
47 skin papilloma 12.0
48 transitional papilloma 12.0
49 atypical choroid plexus papilloma 12.0
50 breast duct papilloma 12.0

Graphical network of the top 20 diseases related to Papilloma:



Diseases related to Papilloma

Symptoms & Phenotypes for Papilloma

MGI Mouse Phenotypes related to Papilloma:

43 (show all 12)
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.25 CDKN2A KRT14 AMOT CDKN2B FSCN1 CDKN1A
2 growth/size/body region MP:0005378 10.25 KRT14 AMOT FSCN1 CDKN1A IGF2 CDKN2A
3 embryo MP:0005380 10.18 AMOT CDKN1A FSCN1 IGF2 CDKN2A RB1
4 mortality/aging MP:0010768 10.17 KRT14 CDKN2B AMOT FSCN1 CDKN1A IGF2
5 digestive/alimentary MP:0005381 10.15 CDKN1A IGF2 CDKN2A KRT14 RB1 KRT5
6 endocrine/exocrine gland MP:0005379 10.11 CDKN2A KRT14 CDKN2B CDKN1A IGF2 UBE3A
7 integument MP:0010771 10.1 CDKN2B CDKN1A IGF2 CDKN2A KRT14 UBE3A
8 liver/biliary system MP:0005370 9.91 CDKN2A CDKN1A IGF2 PTEN RB1 KRT8
9 neoplasm MP:0002006 9.8 CDKN2A KRT14 CDKN2B CDKN1A RB1 TP53
10 no phenotypic analysis MP:0003012 9.76 CDKN2A CDKN2B CDKN1A IGF2 UBE3A RB1
11 pigmentation MP:0001186 9.35 CDKN2A KRT14 RB1 TP53 PTEN
12 reproductive system MP:0005389 9.32 KRT14 CDKN2B CDKN1A IGF2 CDKN2A UBE3A

Drugs & Therapeutics for Papilloma

FDA approved drugs:

# Drug Name Active Ingredient(s) 17 Company Approval Date
1
Cervarix 17 45 Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant GlaxoSmithKline October 2009

Drugs for Papilloma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 255)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cidofovir Approved Phase 4,Phase 2,Phase 1 113852-37-2 60613
2
Chlorhexidine Approved, Vet_approved Phase 4 55-56-1 2713 9552079
3
Imiquimod Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 99011-02-6 57469
4 Liver Extracts Phase 4,Phase 3,Phase 2,Phase 1
5 Vaccines Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
6 Anti-Infective Agents Phase 4,Phase 2,Phase 3,Phase 1
7 Antiviral Agents Phase 4,Phase 3,Phase 2,Phase 1
8 Antibodies Phase 4,Phase 3,Phase 2,Phase 1
9 Immunoglobulins Phase 4,Phase 3,Phase 2,Phase 1
10 Anti-Infective Agents, Local Phase 4
11 Chlorhexidine gluconate Phase 4
12 Dermatologic Agents Phase 4,Phase 3,Phase 2,Phase 1
13 Disinfectants Phase 4
14 Hypoglycemic Agents Phase 4
15 Polyhexamethylene biguanide Phase 4
16 Heptavalent Pneumococcal Conjugate Vaccine Phase 4
17 MF59 oil emulsion Phase 4
18 Adjuvants, Immunologic Phase 4,Phase 2,Phase 3,Phase 1
19 Interferon Inducers Phase 4,Phase 2,Phase 3,Phase 1
20 interferons Phase 4,Phase 2,Phase 3,Phase 1
21
Aminolevulinic acid Approved Phase 3 106-60-5 137
22
Benzocaine Approved, Investigational Phase 3 1994-09-7, 94-09-7 2337
23
Azithromycin Approved Phase 3 83905-01-5 53477736 447043 55185
24
Penicillin G Approved, Vet_approved Phase 3 61-33-6 5904
25
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
26
Fluconazole Approved, Investigational Phase 2, Phase 3 86386-73-4 3365
27
Miconazole Approved, Investigational, Vet_approved Phase 2, Phase 3,Phase 1 22916-47-8 4189
28
Cevimeline Approved Phase 3 107233-08-9 25137844 83898
29
Megestrol acetate Approved, Investigational, Vet_approved Phase 3 595-33-5 11683
30
Doxepin Approved, Investigational Phase 3 1668-19-5 667468 667477
31
Histamine Approved, Investigational Phase 3,Phase 2 51-45-6, 75614-87-8 774
32
Fluorouracil Approved Phase 3,Phase 2,Phase 1 51-21-8 3385
33
Cetuximab Approved Phase 3,Phase 1,Phase 2 205923-56-4 56842117 2333
34
Cisplatin Approved Phase 3,Phase 2,Phase 1 15663-27-1 2767 441203 84093
35
Zinc Approved, Investigational Phase 3 7440-66-6 32051 23994
36 Zinc sulfate Approved, Investigational Phase 3 7733-02-0
37 tannic acid Approved, Nutraceutical Phase 3
38 Pancreatic Polypeptide Investigational Phase 3 59763-91-6
39
Docetaxel Approved May 1996, Investigational Phase 3,Phase 1,Phase 2 114977-28-5 148124 9877265
40 Cytochrome P-450 Enzyme Inhibitors Phase 2, Phase 3
41 Immunosuppressive Agents Phase 3,Phase 1,Phase 2
42 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1
43 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1
44 Penicillin G Benzathine Phase 3
45 Penicillin G Procaine Phase 3
46 Adjuvants, Anesthesia Phase 3
47 Analgesics Phase 3,Phase 2,Phase 1
48 Analgesics, Opioid Phase 3
49 Anesthetics Phase 3
50 Anesthetics, General Phase 3

Interventional clinical trials:

(show top 50) (show all 379)

# Name Status NCT ID Phase Drugs
1 Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls? Unknown status NCT01101750 Phase 4
2 A Health Belief Model Based Intervention to Increase Human Papilloma Virus (HPV) Vaccination Among College Men Completed NCT01431079 Phase 4
3 Antisepsis Regimen in the Surgical Treatment of Human Papilloma Virus Generated Cervical Lesions: Polyhexamethylene Biguanide Versus Chlorhexidine Completed NCT01740245 Phase 4
4 Use of Cidofovir for Recurrent Respiratory Papillomatosis Completed NCT00205374 Phase 4 Cidofovir;Placebo
5 Reactogenicity Study of Cervarix and Gardasil in UK Adolescent Girls Completed NCT00956553 Phase 4
6 Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease Completed NCT00815282 Phase 4
7 Effectiveness, Safety and Immunogenicity of GSK Biologicals' HPV Vaccine GSK580299 (Cervarix TM) Administered in Healthy Adolescents Completed NCT00534638 Phase 4
8 MF59-adjuvanted Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine Completed NCT02225327 Phase 4
9 Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 Years Completed NCT02215863 Phase 4
10 HPV (Human Papilloma Virus) Vaccination After Treatment of Anal Intraepithelial Neoplasia (AIN) Recruiting NCT02087384 Phase 4 Placebo
11 Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts Recruiting NCT03183765 Phase 4 Measles-Mumps-Rubella Vaccine
12 Immunogenicity and Safety of Human Papilloma Virus Vaccine in Solid Organ Transplant Recipients Active, not recruiting NCT02624349 Phase 4 Quadravalent human papillomavirus vaccine
13 Occupational Exposure to Human Papilloma Virus (HPV) and Prophylactic Vaccination Not yet recruiting NCT03350698 Phase 4
14 Vaccination Against Human Papillomavirus (HPV) With the 9-valent Vaccine in HIV-positive Women (the Papillon Study) Not yet recruiting NCT03391921 Phase 4
15 Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD") Terminated NCT00747461 Phase 4
16 Anal Dysplasia Study of Men Who Have Sex With Men Living With HIV Withdrawn NCT01663558 Phase 4 imiquimod
17 Two-dose Schedule of Quadrivalent HPV Recombinant Vaccine in 11-year-old Boys in Mexico City Unknown status NCT02382900 Phase 3
18 4-valent HPV Vaccine to Treat Recurrent Respiratory Papillomatosis in Children Unknown status NCT01995721 Phase 3
19 Topical 5-ALA Photodynamic Therapy for the Treatment of Verruca Vulgaris Unknown status NCT00155584 Phase 3
20 Protecting Young Special Risk Females From Cervical Cancer Through Human Papilloma Virus (HPV) Vaccination Completed NCT00964210 Phase 3 Licensed quadrivalent HPV vaccine, Gardasil
21 Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine Completed NCT00316706 Phase 3
22 Human Papilloma Virus Vaccine Safety and Immunogenicity Trial in Young Adolescent Women With GSK Bio HPV-16/18. Completed NCT00196924 Phase 3
23 Human Papilloma Virus Vaccine Consistency and Non-inferiority Trial in Young Adult Women With GSK Bio HPV-16/18 Completed NCT00169494 Phase 3
24 Safety, Tolerability and Immunogenicity of HPV (Human Papilloma Virus) Vaccine in Healthy Females 9 to 15 Years of Age in India (V501-029) Completed NCT00380367 Phase 3
25 Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18 Completed NCT00122681 Phase 3
26 Human Papilloma Virus (HPV) Vaccine Immunogenicity and Safety Trial in Young and Adult Women With GSK Biologicals' HPV-16/18 Completed NCT00196937 Phase 3
27 Efficacy and Tolerability Study of V501 in Japanese Males (V501-122) Completed NCT01862874 Phase 3
28 Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult Women Completed NCT00337818 Phase 3
29 A Study to Compare Immune Response of V503 to Gardasil in 16- to 26-year-old Men Completed NCT02114385 Phase 3
30 A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019) Completed NCT00090220 Phase 3
31 Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 Years Completed NCT00345878 Phase 3
32 Evaluation of the Immune and Safety Response of GlaxoSmithKline (GSK) Biologicals' HPV Vaccine in Healthy Indian Women Completed NCT00344032 Phase 3
33 Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age Completed NCT00423046 Phase 3
34 Human Papillomavirus (HPV) Registration Study (Gardasil)(V501-023)(COMPLETED) Completed NCT00157950 Phase 3
35 Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus Vaccine With Another Vaccine in Healthy Female Subjects Completed NCT00578227 Phase 3
36 A Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine/Cervarix TM Vaccine in Healthy Females Aged 15-25 Years Completed NCT00485732 Phase 3
37 A Study of Gardasil (V501) in Preadolescents and Adolescents (V501-018) Completed NCT00092547 Phase 3
38 An Investigational Study of Gardasil™ (qHPV, V501) Vaccine in Reducing the Incidence of Anogenital Warts in Young Men (V501-020) Completed NCT00090285 Phase 3
39 Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls Completed NCT01381575 Phase 3
40 Immunogenicity and Safety of GlaxoSmithKline Biologicals' Huma Papillomavirus (HPV) Vaccine 580299 in Healthy Females 15 - 25 Years of Age Completed NCT00552279 Phase 3
41 ITIC (Imiquimod Therapy in Cervical Intraepithelial Neoplasia)-Trial Completed NCT00941252 Phase 2, Phase 3 Topical imiquimod therapy
42 A Study of the Safety, Tolerability, and Immunogenicity of a 9-valent Human Papillomavirus Vaccine ([9vHPV]; V503) Administered to 9- to 15-Year-Old Japanese Girls (V503-008). Completed NCT01254643 Phase 3
43 Effect of WHO-yaws Elimination Strategy in Lihir Island, Papua New Guinea Completed NCT01955252 Phase 3 Azithromycin
44 Immunogenicity and Safety of GSK Biologicals' HPV Vaccine 580299 in Healthy Japanese Females 10-15 Years of Age Completed NCT00492544 Phase 3
45 A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls Completed NCT02562508 Phase 3
46 A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix Completed NCT00264732 Phase 2, Phase 3 Amolimogene;Amolimogene
47 Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts Completed NCT00735462 Phase 3 2.5% imiquimod cream;3.75% imiquimod cream;Placebo cream
48 Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia Completed NCT01164722 Phase 3
49 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
50 Acupuncture or Standard Therapy in Treating Pain and Dysfunction in Patients Who Have Undergone Neck Surgery for Head and Neck Cancer Completed NCT00090337 Phase 3

Search NIH Clinical Center for Papilloma

Inferred drug relations via UMLS 69 / NDF-RT 47 :


Genetic Tests for Papilloma

Anatomical Context for Papilloma

MalaCards organs/tissues related to Papilloma:

38
Breast, Testes, Skin, Cervix, Lung, Kidney, Brain

Publications for Papilloma

Articles related to Papilloma:

(show top 50) (show all 1862)
# Title Authors Year
1
Laryngeal squamous cell papilloma is highly associated with human papillomavirus. ( 29447361 )
2018
2
Human papilloma virus-specific T cells can be generated from naA^ve T cells for use as an immunotherapeutic strategy for immunocompromised patients. ( 29331266 )
2018
3
Human Papilloma Virus Vaccination Among Adolescents in a Community Clinic Before and After Intervention. ( 29368102 )
2018
4
Improving human papilloma virus vaccination rates throughout military treatment facilities. ( 29433899 )
2018
5
Amyotrophic Lateral Sclerosis after Receiving the Human Papilloma Virus Vaccine: A Case Report of a 15-year-old Girl. ( 29434138 )
2018
6
Human Papilloma Virus (HPV) self-sampling: do women accept it? ( 29385850 )
2018
7
Association between Human Papilloma Virus (HPV) vaccination and risk of Multiple Sclerosis: A systematic review. ( 29333935 )
2018
8
Human papilloma virus: Apprehending the link with carcinogenesis and unveiling new research avenues (Review). ( 29393378 )
2018
9
Endoscopic mucosal resection of rectal squamous cell papilloma. ( 29351698 )
2018
10
Prognostic Significance of Human Papilloma Virus and p16 Expression in Patients with Vulvar Squamous Cell Carcinoma who Received Radiotherapy. ( 29449057 )
2018
11
Human papilloma virus: An etiological and prognostic factor for oral cancer? ( 29322686 )
2018
12
Human Papilloma Virus 16/18: Fabricator of Trouble in Oral Squamous Cell Carcinoma. ( 29432879 )
2018
13
Use of intraoperative negative margins reduces inverted papilloma recurrence. ( 29336292 )
2018
14
Assessing the performance of a Loop Mediated Isothermal Amplification (LAMP) assay for the detection and subtyping of high-risk suptypes of Human Papilloma Virus (HPV) for Oropharyngeal Squamous Cell Carcinoma (OPSCC) without DNA purification. ( 29422018 )
2018
15
Atypical Presentation of Squamous Papilloma. ( 29342034 )
2018
16
Oncogenic Viruses and Breast Cancer: Mouse Mammary Tumor Virus (MMTV), Bovine Leukemia Virus (BLV), Human Papilloma Virus (HPV), and Epstein-Barr Virus (EBV). ( 29404275 )
2018
17
The clinical behavior of sinonasal inverted papilloma with cellular dysplasia: case series and review of the literature. ( 28597339 )
2017
18
Challenging Atypical Breast Lesions Including Flat Epithelial Atypia, Radial Scar, and Intraductal Papilloma. ( 28766216 )
2017
19
Intraductal papilloma of the breast in an 11-year-old male patient: a case report. ( 28353086 )
2017
20
Bacterial vaginosis, human papilloma virus and herpes viridae do not predict vaginal HIV RNA shedding in women living with HIV in Denmark. ( 28569142 )
2017
21
Lacrimal Caruncle Nevus with Papilloma. ( 29422855 )
2017
22
Different characteristics of a single sinonasal inverted papilloma from sequential PET-CT: A case report. ( 29384975 )
2017
23
Incidence rates of Guillain BarrAc (GBS), chronic fatigue/systemic exertion intolerance disease (CFS/SEID) and postural orthostatic tachycardia syndrome (POTS) prior to introduction of human papilloma virus (HPV) vaccination among adolescent girls in Finland, 2002-2012. ( 28720463 )
2017
24
Incidental choroid plexus papilloma in a child: A difficult decision. ( 28607820 )
2017
25
Human Papilloma Virus-Associated Lips Verrucous Carcinoma in HIV-Infected Male. ( 28565927 )
2017
26
Choroid plexus papilloma. ( 28413558 )
2017
27
Management of maxillary sinus inverted papilloma via endoscopic partial medial maxillectomy with an inferior turbinate reversing approach. ( 28936551 )
2017
28
Attitudes towards Human Papilloma Virus Vaccination in the Latin American Andean Region. ( 28885601 )
2017
29
Esophageal Squamous Papilloma: A Case Series and Literature Review. ( 28834319 )
2017
30
Management of inverted papilloma: review. ( 28179032 )
2017
31
The rapid change in sinonasal inverted papilloma incidence - the epidemiological analysis. ( 28485293 )
2017
32
The Management Strategy of Benign Solitary Intraductal Papilloma on Breast Core Biopsy. ( 28438672 )
2017
33
Accidentally diagnosed transitional cell papilloma of the lacrimal sac. ( 28860918 )
2017
34
Dysphagia caused by an inverted papilloma. ( 29237672 )
2017
35
Will they lead by example? Assessment of vaccination rates and attitudes to human papilloma virus in millennial medical students. ( 28056900 )
2017
36
Expression pattern of estroprogestinic receptors in sinonasal inverted papilloma. ( 28473663 )
2017
37
Bone involvement: Histopathological evidence for endoscopic management of sinonasal inverted papilloma. ( 28722237 )
2017
38
Human Papilloma Virus Vaccination and Incidence of Ocular Surface Squamous Neoplasia. ( 27898614 )
2017
39
Poly-MVA attenuates 7,12- dimethylbenz[a]anthracene initiated and croton oil promoted skin papilloma formation on mice skin. ( 28976135 )
2017
40
Endoscopic surgery of a sinonasal inverted papilloma: Surgical strategy, follow-up, and recurrence rate. ( 28234155 )
2017
41
Atypical choroid plexus papilloma: spontaneous resolution of diffuse leptomeningeal contrast enhancement after primary tumor removal in 2 pediatric cases. ( 28686125 )
2017
42
Molecular alterations in lesions of anogenital mammary-like glands and their mammary counterparts including hidradenoma papilliferum, intraductal papilloma, fibroadenoma and phyllodes tumor. ( 28648934 )
2017
43
Detection of Human Papilloma virus by Molecular method from Patients Attending at Colposcopy Clinic of Mymensingh Medical College Hospital, Mymensingh. ( 28919616 )
2017
44
MRI-Based Texture Analysis to Differentiate Sinonasal Squamous Cell Carcinoma from Inverted Papilloma. ( 28255033 )
2017
45
Esophageal squamous papillomas with focal dermal hypoplasia and eosinophilic esophagitis. ( 28405153 )
2017
46
Gene promoter methylation and protein expression of BRMS1 in uterine cervix in relation to high-risk human papilloma virus infection and cancer. ( 28381193 )
2017
47
Inverted papilloma of middle ear and temporal bone. ( 28233515 )
2017
48
Infection Modes and Subtypes of Human Papilloma Virus in Patients. ( 28877828 )
2017
49
Lesson of the month 2: A choroid plexus papilloma manifesting as anorexia nervosa in an adult. ( 28365635 )
2017
50
Multifocal sinonasal inverted papilloma with middle ear involvement. ( 28966465 )
2017

Variations for Papilloma

Expression for Papilloma

Search GEO for disease gene expression data for Papilloma.

Pathways for Papilloma

Pathways related to Papilloma according to GeneCards Suite gene sharing:

(show all 39)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.48 FLG IVL KRT10 KRT13 KRT14 KRT20
2
Show member pathways
13.02 CDKN1A CDKN2A CDKN2B PTEN RB1 TP53
3
Show member pathways
12.95 CDKN1A IGF2 PTEN RB1 TP53 UBE3A
4 12.76 CDKN1A CDKN2A CDKN2B IGF2 PTEN RB1
5
Show member pathways
12.67 CDKN1A CDKN2A CDKN2B IGF2 PTEN RB1
6
Show member pathways
12.55 CDKN1A CDKN2A CDKN2B RB1 TP53
7 12.5 CDKN1A CDKN2A FSCN1 PTEN TP53
8 12.4 CDKN1A CDKN2A CDKN2B RB1 TP53
9
Show member pathways
12.36 CDKN1A IGF2 PTEN TP53
10
Show member pathways
12.35 CDKN1A CDKN2A PTEN RB1 TP53
11 12.35 AMOT FSCN1 KRT10 KRT13 KRT20 KRT5
12 12.34 CDKN1A CDKN2A CDKN2B RB1 TP53
13
Show member pathways
12.32 CDKN1A CDKN2A CDKN2B RB1 TP53
14
Show member pathways
12.23 CDKN1A PTEN RB1 TP53
15
Show member pathways
12.19 CDKN1A CDKN2A CDKN2B RB1
16 12.15 CDKN1A CDKN2A CDKN2B RB1 TP53 UBE3A
17
Show member pathways
12.13 CDKN1A CDKN2A RB1 TP53
18 12.05 CDKN1A PTEN RB1 TP53
19 12.05 CDKN1A CDKN2A PTEN TP53
20 11.99 CDKN1A CDKN2A RB1 TP53 UBE3A
21 11.97 CDKN1A CDKN2A PTEN TP53
22
Show member pathways
11.94 KRT13 KRT14 KRT5 KRT8
23 11.94 CDKN1A CDKN2A CDKN2B PTEN RB1 TP53
24 11.86 CDKN1A CDKN2A PTEN RB1 TP53
25 11.83 CDKN1A PTEN RB1 UBE3A
26 11.8 CDKN1A RB1 TP53
27 11.77 CDKN1A CDKN2B PTEN RB1 TP53
28 11.75 CDKN1A KRT14 KRT5 TP53
29 11.71 CDKN1A CDKN2A TP53
30 11.69 CDKN1A CDKN2A RB1 TP53
31
Show member pathways
11.68 FLG IVL KRT10 KRT13 KRT14 KRT20
32 11.49 CDKN1A CDKN2A RB1 TP53
33 11.48 CDKN1A CDKN2A IGF2 PTEN RB1 TP53
34 11.3 CDKN2A CDKN2B TP53
35 11.22 CDKN1A CDKN2B PTEN RB1 TP53
36 11.08 CDKN2A RB1 TP53
37
Show member pathways
11.07 CDKN1A CDKN2A TP53
38 10.75 CDKN1A TP53
39
Show member pathways
10.56 CDKN1A TP53

GO Terms for Papilloma

Cellular components related to Papilloma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytosol GO:0005829 9.89 AMOT CDKN1A CDKN2A CDKN2B FLG FSCN1
2 cornified envelope GO:0001533 9.5 FLG IVL KRT10
3 keratin filament GO:0045095 9.46 KRT13 KRT14 KRT5 KRT8
4 intermediate filament GO:0005882 9.17 FLG KRT10 KRT13 KRT14 KRT20 KRT5
5 cytoplasm GO:0005737 10.21 CDKN1A CDKN2A CDKN2B FSCN1 IVL KRT10
6 nucleus GO:0005634 10.13 AMOT CDKN1A CDKN2A CDKN2B FLG KRT10

Biological processes related to Papilloma according to GeneCards Suite gene sharing:

(show all 18)
# Name GO ID Score Top Affiliating Genes
1 negative regulation of cell proliferation GO:0008285 9.91 CDKN1A CDKN2A CDKN2B PTEN RB1 TP53
2 keratinocyte differentiation GO:0030216 9.71 FLG IVL KRT10
3 negative regulation of epithelial cell proliferation GO:0050680 9.69 CDKN2B PTEN RB1
4 peptide cross-linking GO:0018149 9.67 FLG IVL KRT10
5 Ras protein signal transduction GO:0007265 9.67 CDKN1A CDKN2A RB1 TP53
6 cell cycle arrest GO:0007050 9.65 CDKN1A CDKN2A CDKN2B RB1 TP53
7 regulation of cyclin-dependent protein serine/threonine kinase activity GO:0000079 9.63 CDKN1A CDKN2B PTEN
8 response to arsenic-containing substance GO:0046685 9.58 CDKN1A PTEN
9 negative regulation of phosphorylation GO:0042326 9.58 CDKN1A CDKN2A CDKN2B
10 response to UV-B GO:0010224 9.57 IVL TP53
11 hemidesmosome assembly GO:0031581 9.56 KRT14 KRT5
12 hepatocyte apoptotic process GO:0097284 9.55 KRT8 RB1
13 prostate gland growth GO:0060736 9.52 PTEN UBE3A
14 replicative senescence GO:0090399 9.5 CDKN1A CDKN2A TP53
15 keratinization GO:0031424 9.5 IVL KRT10 KRT13 KRT14 KRT20 KRT5
16 signal transduction by p53 class mediator GO:0072331 9.48 CDKN1A TP53
17 negative regulation of G1/S transition of mitotic cell cycle GO:2000134 9.46 CDKN1A CDKN2B PTEN RB1
18 cornification GO:0070268 9.23 FLG IVL KRT10 KRT13 KRT14 KRT20

Molecular functions related to Papilloma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 protein kinase binding GO:0019901 9.72 CDKN1A CDKN2A CDKN2B PTEN TP53
2 structural constituent of epidermis GO:0030280 9.37 FLG KRT10
3 structural molecule activity GO:0005198 9.35 FLG IVL KRT10 KRT13 KRT8
4 disordered domain specific binding GO:0097718 9.33 CDKN2A RB1 TP53
5 cyclin-dependent protein serine/threonine kinase inhibitor activity GO:0004861 8.8 CDKN1A CDKN2A CDKN2B
6 protein binding GO:0005515 10.21 AMOT CDKN1A CDKN2A CDKN2B FLG FSCN1

Sources for Papilloma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....